Early results from a study suggest that testosterone implanted under the skin as a pellet helps ease menopausal symptoms without increasing breast cancer risk.
Two studies suggest that a low dose of the antidepressant medicine Paxil can lower the number and severity of hot flashes in some women.
Research suggests that Lexapro, an antidepressant medicine, can lower the number and severity of hot flashes in some menopausal women.
A new analysis disagrees with earlier conclusions about HRT and increased breast cancer risk; Breastcancer.org supports the earlier conclusions that point to an association between HRT and increased risk and urges women to approach HRT use with caution and thoroughly discuss the pros and cons with their doctors before making a decision.
New research suggests that the antidepressant medicine Celexa (chemical name: citalopram) can lower the number and severity of hot flashes in post-menopausal women.
Researchers have developed recommendations on managing menopausal symptoms for women who've been diagnosed with breast cancer.
New research confirms that hormone replacement therapy increases the risk of hormone-receptor-positive breast cancer.
Overall, neither systemic nor vaginal hormone replacement therapy (HRT) seemed to increase the risk of breast cancer recurrence (the cancer coming back) in women diagnosed with early-stage, estrogen receptor-positive disease. Still, using vaginal HRT slightly increased recurrence risk in women who received an aromatase inhibitor.
On Sept. 1, 2011 the U.S. Food and Drug Administration warned doctors and patients that Reclast may cause severe kidney problems.
New research suggests that breast cancer risk is higher in women who use HRT during the first 5 years after menopause starts compared to women who wait more than 5 years to start HRT.
Hormone replacement therapy increases the risk of breast cancer recurrence (the cancer coming back), so women with a history of the disease should not take HRT.
The results of a small study suggest that electroacupuncture can help ease hot flashes as much or more than gabapentin, improving women's sleep quality.
Breast cancer diagnosed after combination HRT tends to have a better prognosis than cancer diagnosed after estrogen-only HRT.
A new study found that certain risk factors for breast cancer affect the risk of specific types of breast cancer in different ways.
Most family medicine, internal medicine, and obstetrician-gynecologist (ob/gyn) doctors recommend gradually stopping HRT over time instead of suddenly stopping it.
Another study links hormone replacement therapy (HRT) and increased breast cancer risk.
A specific type of online therapy, called internet-based cognitive behavioral therapy, can help reduce the toll of hot flashes, night sweats, and other menopausal symptoms caused by breast cancer treatments.
SSRIs are linked to a higher fracture risk, but the actual number of women who broke a bone is low.
Twelve weeks of acupuncture seems to offer the same relief from hot flashes as 12 weeks of Effexor (chemical name: venlafaxine), an antidepressant.
Research shows that flaxseed doesn't ease hot flashes.
A new analysis of Women's Health Initiative data shows that women who use combination HRT are nearly twice as likely to die from breast cancer compared to women who don't use HRT.
Tai chi eases insomnia in breast cancer survivors just as well as cognitive behavioral therapy.
Menopausal women who took isoflavone tablets every day for 2 years didn't get any relief from hot flashes; the isoflavone tablets also didn't prevent bone loss.
A new study suggests that black cohosh may possibly reduce breast cancer risk.